Posted inEmerging Market
Vaxcyte Vaccine Gamble: What the Next Year Holds for PCVX
Discover why the upcoming year is critical for Vaxcyte as the biotech company advances its innovative vaccine pipeline and strategic goals.
Posted inMarket
Vaxcyte Strengthens Leadership Team and Accelerates Clinical Trial Timeline
Vaxcyte appoints two new executive leaders and narrows the anticipated trial timeline for its key pneumococcal conjugate vaccine candidate.
